Armed with $3.5M Stash, Vala Sciences to Sell Cellular Imaging Software, Reagents | GenomeWeb

With approximately $3.5 million from NIH grants and private investors under its belt, La Jolla, Calif.-based biotech startup Vala Sciences debuted last week as a provider of reagents and software for conducting image-based cell assays for drug screening and cell biology research.

Jeffrey Price, an associate professor at the La Jolla-based Burnham Institute and adjunct professor of bioengineering at the University of California, San Diego, is one of Vala’s co-founders, and will serve as chairman and CEO.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.